Abstract:Large scale genomic studies are cataloguing tens of thousands of cancer mutations across a wide spectrum of tumor types. Conventional DNA sequencing methods have limitations in terms of identify mutations at high resolution among single cells. Moreover, determining cancer mutations' phenotype and function remains an enormous challenge - most mutations are assigned to the category of variants of unknown significance. In-silico functional predictions of cancer mutations are frequently used as a stopgap solution. However, these computational methods lack the ability to make refined biological and functional predictions. We demonstrated a new single cell experimental strategy that accelerates the discovery of cancer mutations and their characterization. This genomic technology framework does the following: (1) identify disease-related mutations at the resolution of individual cells from tumors or cell lines; (2) genome engineer these candidate mutations into cellular experimental systems for further biological characterization. First, we developed a single cell approach to identify cancer somatic mutations and even gene fusion rearrangements found in coding regions of mRNAs. Primary tumors are processed into single cell RNA-seq libraries and analyzed with nanopore long read sequencing. Across thousands of cells from primary tumors, we identified single cell mutations from the nanopore long reads that covered cancer gene transcripts. This approach allows us to even identify cancer rearrangements at single cell resolution. Next, we used short-read single cell transcriptomes to characterize the cell type and determine the gene expression characteristics of those cells with mutations. For single cell phenotypic studies, we developed a highly multiplexed technology using CRISPR base editors to directly engineer hundreds of mutations into their original genes among single cells and determine their transcriptional phenotype. Among specific individual cells, nanopore-based long-read sequencing identifies these modelled mutations directly from a target's transcript sequence. Then, we integrate this single cell mutation data with the short-read transcriptome profile from the same individual cell. Therefore, we determine both the genotype and phenotype of a given engineered mutation from an individual cell. In summary, our work demonstrates a new, direct and highly scalable method for identifying, modelling and functionally assessing cancer mutation phenotype at single cell resolution. This approach enables the broader assessment of cancer mutations impact on tumor biology and clinical ramifications. Citation Format: Susan M. Grimes, Heonseok Kim, Sharmili Roy, Anuja Sathe, Billy T. Lau, Hanlee P. Ji. Solving the cancer mutation conundrum: A single cell, massively parallel approach for cancer mutation discovery, genome modelling and functional characterization [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 2928.

A High-Fidelity Method for Genomic Sequencing of Single Somatic Cells Reveals a Very High Mutational Burden

Single-cell whole-genome sequencing reveals somatic mutation signatures in normal somatic cells predictive of cancer later in life

Single-molecule, Quantitative Detection of Low-Abundance Somatic Mutations by High-Throughput Sequencing

Analyzing somatic mutations by single-cell whole-genome sequencing

Age-related somatic mutation burden in human tissues.

Whole genome DNA sequencing provides an atlas of somatic mutagenesis in healthy human cells and identifies a tumor-prone cell type

Direct, Genome-Wide Assessment of Dna Mutations in Single Cells

Pathogenic Mechanisms of Somatic Mutation and Genome Mosaicism in Aging

Abstract 5400: Accurate identification of single nucleotide variants in whole genome amplified single cells

Measures of genetic diversification in somatic tissues at bulk and single-cell resolution

Analysis of Somatic Mutations in Senescent Cells Using Single-Cell Whole-Genome Sequencing

Single-molecule genome-wide mutation profiles of cell-free DNA for non-invasive detection of cancer

Somatic mutations in aging and disease

Somatic Point Mutation Calling in Low Cellularity Tumors

Detecting Somatic Mutations Without Matched Normal Samples Using Long Reads

Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencing

Abstract 2928: Solving the cancer mutation conundrum: A single cell, massively parallel approach for cancer mutation discovery, genome modelling and functional characterization

[Detection of somatic mutations in deteriorated cell of peritoneal mesothelioma by whole genome sequencing].

Comparing the predictors of mutability among healthy human tissues inferred from mutations in single cell genome data

Single-cell Whole-Genome Sequencing Reveals the Functional Landscape of Somatic Mutations in B Lymphocytes Across the Human Lifespan

Somatic mutation rates scale with lifespan across mammals